Journal of Oncology & Targeted Therapies
Aims and Scope – Journal of Oncology & Targeted Therapies
The aim of the Journal of Oncology & Targeted Therapies: Open Access is to increase awareness, inspire innovation, and promote research interest in the expanding fields of oncology and targeted cancer therapies. The journal serves as a platform to share meaningful advances in cancer biology, diagnostics, treatment strategies, and personalized medicine.
To support this mission, the Journal of Oncology & Targeted Therapies welcomes a wide range of scholarly contributions, including: original research articles, review articles, case reports, image articles, short communications, commentaries, opinions, theses, letters to the editor, editorials, science guidelines.
These submissions provide valuable insights into the mechanisms of cancer development, progression, and targeted therapeutic approaches, enhancing our understanding of oncology as a multidisciplinary field.
The journal encompasses a wide range of topics in cancer research, including but not limited to:
- Molecular oncology and cancer genetics
- Tumor biology and cancer signaling pathways
- Clinical diagnosis, staging, and classification of cancers
- Surgical oncology and minimally invasive tumor resections
- Radiation oncology and advanced radiotherapy techniques
- Medical oncology: chemotherapy, targeted treatments, hormone therapy, and immunotherapy
- Pediatric oncology and management of childhood cancers
- Hematologic malignancies: leukemia, lymphoma, myeloma
- Cancer prevention, screening, and early detection methods
- Tumor microenvironment and cancer metastasis mechanisms
- Biomarkers, liquid biopsies, and precision medicine
- Cancer immunotherapy including checkpoint inhibitors and CAR-T therapy
- Psycho-oncology and psychosocial support for cancer patients
- Palliative care and end-of-life management
- Cancer epidemiology, risk assessment, and health disparities
- Experimental therapeutics and novel drug development
- Clinical trials design and outcomes in oncology
- Radiology and molecular imaging for diagnosis and treatment monitoring
- Oncologic pathology and molecular diagnostics
- Survivorship, rehabilitation, and long-term follow-up care
- Nutritional oncology and lifestyle interventions
- Cancer health policy, education, and advocacy
- Integrative and complementary oncology approaches
- Genetic counseling and familial cancer syndromes
- Tumor immunology and cancer vaccine research
- Bioinformatics and computational oncology
- Cancer stem cell research and tumor heterogeneity
- Quality of life and functional outcomes in cancer patients
Journal of Oncology & Targeted Therapies: Open Access strongly supports the Open Access initiative. All articles—whether abstracts or full texts—are published in HTML, PDF, and XML formats and made freely accessible online immediately after publication, ensuring global visibility and unrestricted access to knowledge.
The journal is published by IBMSR Journals and remains committed to keeping pace with the latest advances in oncology and targeted therapy research.
